GSK plc (LON:GSK)
1,631.50
+3.50 (0.21%)
Oct 16, 2025, 8:44 AM BST
GSK plc Revenue
GSK plc had revenue of 7.99B GBP in the quarter ending June 30, 2025, with 1.29% growth. This brings the company's revenue in the last twelve months to 31.63B, up 0.59% year-over-year. In the year 2024, GSK plc had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.63B
Revenue Growth
+0.59%
P/S Ratio
2.07
Revenue / Employee
460.90K
Employees
68,629
Market Cap
65.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Oxford Nanopore Technologies | 204.69M |
GSK plc News
- 18 hours ago - Pfizer (PFE) and GSK's ViiV Shows Promising HIV Therapy Results - GuruFocus
- 18 hours ago - SCYNEXIS (SCYX) Secures $22 Million from GlaxoSmithKline Settlement - GuruFocus
- 20 hours ago - GSK chief doesn’t buy that the CEO role has become unsustainable: ‘There are few things more obnoxious in life than CEOs complaining about how hard their life is’ - Fortune
- 1 day ago - Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Benzinga
- 1 day ago - GSK Secures Approval for Shingles Vaccine Shingrix in China - GuruFocus
- 1 day ago - GSK gets China nod for Shingrix to prevent shingles in adults aged 18+ - Seeking Alpha
- 1 day ago - GSK Receives China Approval for Shingrix to Prevent Shingles in At-Risk Adults - GuruFocus
- 1 day ago - Unilever’s £15bn Bid for GSK Consumer Health Ignites FTSE Frenzy, Shares Soar 4% on Deal Speculation - ABC Money